RS20050420A - Prevention and treatment of alzheimer's disease - Google Patents
Prevention and treatment of alzheimer's diseaseInfo
- Publication number
- RS20050420A RS20050420A YUP-2005/0420A YUP20050420A RS20050420A RS 20050420 A RS20050420 A RS 20050420A YU P20050420 A YUP20050420 A YU P20050420A RS 20050420 A RS20050420 A RS 20050420A
- Authority
- RS
- Serbia
- Prior art keywords
- inhibitor
- disease
- alzheimer
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
The invention concerns the use of biliary acid intestinal recapture inhibitors for preventing and treating Alzheimer's disease, optionally combined with a HMG-CoA reductase inhibitor, a cholesterol capture inhibitor, a cholesterol synthesis capture inhibitor or an APP secretase inhibitor.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0215722A FR2848452B1 (en) | 2002-12-12 | 2002-12-12 | APPLICATION OF INTESTINAL BILIARY ACID RECAPTURE INHIBITORS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE |
PCT/FR2003/003654 WO2004062652A1 (en) | 2002-12-12 | 2003-12-10 | Prevention and treatment of alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
RS20050420A true RS20050420A (en) | 2007-04-10 |
Family
ID=32338722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-2005/0420A RS20050420A (en) | 2002-12-12 | 2003-12-10 | Prevention and treatment of alzheimer's disease |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1572174A1 (en) |
JP (1) | JP2006514063A (en) |
KR (1) | KR20050084250A (en) |
CN (1) | CN1726016A (en) |
AR (1) | AR042354A1 (en) |
AU (1) | AU2003296802A1 (en) |
BR (1) | BR0317280A (en) |
CA (1) | CA2507945A1 (en) |
CO (1) | CO5700712A2 (en) |
FR (1) | FR2848452B1 (en) |
HR (1) | HRP20050534A2 (en) |
MA (1) | MA27500A1 (en) |
MX (1) | MXPA05005556A (en) |
NO (1) | NO20053341L (en) |
NZ (1) | NZ540496A (en) |
PE (1) | PE20040770A1 (en) |
PL (1) | PL377110A1 (en) |
RS (1) | RS20050420A (en) |
RU (1) | RU2005121909A (en) |
TW (1) | TW200503707A (en) |
WO (1) | WO2004062652A1 (en) |
ZA (1) | ZA200504656B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
NZ546887A (en) | 2003-11-03 | 2009-04-30 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
JP4996926B2 (en) | 2004-02-05 | 2012-08-08 | プロビオドルグ エージー | Novel inhibitors of glutaminyl cyclase |
WO2006050359A2 (en) | 2004-11-02 | 2006-05-11 | Northwestern University | Pyridazine compounds and methods |
CA2650711A1 (en) | 2006-04-28 | 2007-11-08 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
PL2157973T3 (en) * | 2007-05-22 | 2015-12-31 | Otsuka Pharma Co Ltd | A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease |
MX363161B (en) * | 2011-10-28 | 2019-03-13 | Lumena Pharmaceuticals Inc | Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease. |
US20140243281A1 (en) * | 2011-10-28 | 2014-08-28 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2040996A1 (en) * | 1990-05-02 | 1991-11-03 | Robert L. Albright | Composition and method for controlling cholesterol |
CA2104594C (en) * | 1991-02-22 | 2004-05-11 | Howard K. Shapiro | Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
JP2001508762A (en) * | 1996-06-27 | 2001-07-03 | ジー.ディー.サール アンド カンパニー | Particles consisting of an amphiphilic copolymer having a cross-linked outer shell region and inner core region, useful for pharmaceutical and other applications |
US5985936A (en) * | 1997-12-18 | 1999-11-16 | Forbes Medi-Tech, Inc. | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
ES2257824T3 (en) * | 1998-01-28 | 2006-08-01 | Warner-Lambert Company Llc | METHOD TO TREAT ALZHEIMER'S DISEASE. |
US6080778A (en) * | 1998-03-23 | 2000-06-27 | Children's Medical Center Corporation | Methods for decreasing beta amyloid protein |
DE19825804C2 (en) * | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation and medicaments containing these compounds |
US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
DE19845405C2 (en) * | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Aryl-substituted propanolamine derivatives and their use |
WO2001056579A1 (en) * | 2000-02-04 | 2001-08-09 | Esperion Therapeutics Inc. | Methods for treating alzheimer's disease |
US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
SE0104334D0 (en) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
TWI329111B (en) * | 2002-05-24 | 2010-08-21 | X Ceptor Therapeutics Inc | Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
-
2002
- 2002-12-12 FR FR0215722A patent/FR2848452B1/en not_active Expired - Fee Related
-
2003
- 2003-12-10 KR KR1020057010595A patent/KR20050084250A/en not_active Application Discontinuation
- 2003-12-10 AU AU2003296802A patent/AU2003296802A1/en not_active Abandoned
- 2003-12-10 PE PE2003001247A patent/PE20040770A1/en not_active Application Discontinuation
- 2003-12-10 RS YUP-2005/0420A patent/RS20050420A/en unknown
- 2003-12-10 WO PCT/FR2003/003654 patent/WO2004062652A1/en active Application Filing
- 2003-12-10 MX MXPA05005556A patent/MXPA05005556A/en not_active Application Discontinuation
- 2003-12-10 PL PL377110A patent/PL377110A1/en not_active Application Discontinuation
- 2003-12-10 CA CA002507945A patent/CA2507945A1/en not_active Abandoned
- 2003-12-10 AR ARP030104540A patent/AR042354A1/en not_active Application Discontinuation
- 2003-12-10 EP EP03815109A patent/EP1572174A1/en not_active Withdrawn
- 2003-12-10 NZ NZ540496A patent/NZ540496A/en unknown
- 2003-12-10 RU RU2005121909/15A patent/RU2005121909A/en not_active Application Discontinuation
- 2003-12-10 CN CNA2003801059727A patent/CN1726016A/en active Pending
- 2003-12-10 JP JP2004566119A patent/JP2006514063A/en not_active Abandoned
- 2003-12-10 BR BR0317280-5A patent/BR0317280A/en not_active IP Right Cessation
- 2003-12-11 TW TW092134949A patent/TW200503707A/en unknown
-
2005
- 2005-06-07 ZA ZA200504656A patent/ZA200504656B/en unknown
- 2005-06-09 CO CO05056010A patent/CO5700712A2/en not_active Application Discontinuation
- 2005-06-10 HR HR20050534A patent/HRP20050534A2/en not_active Application Discontinuation
- 2005-06-10 MA MA28329A patent/MA27500A1/en unknown
- 2005-07-08 NO NO20053341A patent/NO20053341L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20040770A1 (en) | 2004-12-10 |
HRP20050534A2 (en) | 2006-11-30 |
FR2848452A1 (en) | 2004-06-18 |
CO5700712A2 (en) | 2006-11-30 |
BR0317280A (en) | 2005-11-08 |
CA2507945A1 (en) | 2004-07-29 |
NO20053341D0 (en) | 2005-07-08 |
MA27500A1 (en) | 2005-08-01 |
AR042354A1 (en) | 2005-06-15 |
NO20053341L (en) | 2005-09-07 |
MXPA05005556A (en) | 2005-07-26 |
JP2006514063A (en) | 2006-04-27 |
NZ540496A (en) | 2008-04-30 |
FR2848452B1 (en) | 2007-04-06 |
RU2005121909A (en) | 2006-01-20 |
PL377110A1 (en) | 2006-01-23 |
ZA200504656B (en) | 2006-08-30 |
WO2004062652A1 (en) | 2004-07-29 |
TW200503707A (en) | 2005-02-01 |
CN1726016A (en) | 2006-01-25 |
KR20050084250A (en) | 2005-08-26 |
AU2003296802A1 (en) | 2004-08-10 |
EP1572174A1 (en) | 2005-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1509232E (en) | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer`s disease | |
GB0223040D0 (en) | Therapeutic compounds | |
MXPA01006472A (en) | Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications. | |
HUP0402629A3 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
WO2000061167A3 (en) | TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-λB ACTIVITY INHIBITORS | |
EP1638950A4 (en) | Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | |
MY121399A (en) | Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications | |
SI1663185T1 (en) | Prevention and treatment of inflammation-induced and/or immune-mediated bone loss | |
ZA200410011B (en) | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment | |
HK1073313A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
AP2004002951A0 (en) | "Combination of Eplerenone and an HMG CoA Reductase Inhibitor". | |
AU2004208615B2 (en) | Medicine for prevention of and treatment for arteriosclerosis and hypertension | |
PL377344A1 (en) | Medicine for prevention of and treatment for arteriosclerosis and hypertension | |
IL174536A0 (en) | Therapeutic treatment | |
EA200702212A1 (en) | METHOD OF TREATMENT OR PREVENTION OF BONE DESTRUCTION OR OSTEOPOROSIS | |
AU2003231252A1 (en) | Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease | |
NO20053341L (en) | Prevention and treatment of Alzheimer's disease. | |
WO2004043456A8 (en) | Cholesterol absorption inhibitors for the treatment of demyelination | |
MXPA05009986A (en) | Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders. | |
TW200635900A (en) | Chemical compound and its use | |
TW200714280A (en) | Novel method of treating hyperlipidemia | |
HK1080408A1 (en) | Use of brimonidine in the treatment of dementia a nd parkinson | |
WO2004028456A3 (en) | Method and composition for treating neurodegenerative disorders | |
WO2004080450A3 (en) | Combined use of a fibrate and orlistat for the treatment of obesity | |
UA85187C2 (en) | 2-aminobenzoyl derivatives |